E-LIB Suche - Ergebnisse für: Dei Tos, G

1

Wait watchers: the application of a waiting list active man..:

De Belvis, A. G. ; Marino, M. ; Avolio, M....
International Journal for Quality in Health Care. 25 (2013) 2 - p. 205-212 , 2013

Link: https://doi.org/10.1093/..

2

91P Single-center experience on immune checkpoint inhibitor..:

Dolcan, A.M. ; Ferraro, D.A. ; Papadopoulos, S....
ESMO Open. 9 (2024) - p. 102480 , 2024

Link: https://doi.org/10.1016/..

3

Oncologie [2020 oncology update]:

Dei Tos, G ; Galli Vareia, I ; Huber, A...
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.723.0201. , 2021

Link: https://serval.unil.ch/n..

4

Druggable targets meet oncogenic drivers: opportunities and..:

Danesi, R. ; Fogli, S. ; Indraccolo, S....
ESMO Open. 6 (2021) 2 - p. 100040 , 2021

Link: https://doi.org/10.1016/..

5

Intratumor morphologic and transcriptomic heterogeneity in ..:

Angerilli, V. ; Fontana, E. ; Lonardi, S....
ESMO Open. 6 (2021) 4 - p. 100211 , 2021

Link: https://doi.org/10.1016/..

6

Diagnosis and management of tropomyosin receptor kinase (TR..:

Demetri, G.D. ; Antonescu, C.R. ; Bjerkehagen, B....
Annals of Oncology. 31 (2020) 11 - p. 1506-1517 , 2020

Link: https://doi.org/10.1016/..

7

Extra-axial chordoma: a clinicopathologic analysis of six c..:

Righi, A. ; Sbaraglia, M. ; Gambarotti, M....
Virchows Archiv. 472 (2018) 6 - p. 1015-1020 , 2018

Link: https://doi.org/10.1007/..

8

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Pr..:

Casali, P.G. ; Abecassis, N. ; Bauer, S....
Annals of Oncology. 29 (2018) - p. iv51-iv67 , 2018

Link: https://doi.org/10.1093/..

9

Patient-derived solitary fibrous tumour xenografts predict ..:

Stacchiotti, S. ; Saponara, M. ; Frapolli, R....
European Journal of Cancer. 76 (2017) - p. 84-92 , 2017

Link: https://doi.org/10.1016/..

10

Histology and grading are important prognostic factors in s..:

Bianchi, G. ; Sambri, A. ; Righi, A....
European Journal of Surgical Oncology. 43 (2017) 9 - p. 1733-1739 , 2017

Link: https://doi.org/10.1016/..

11

Short, full-dose adjuvant chemotherapy (CT) in high-risk ad..:

Gronchi, A. ; Stacchiotti, S. ; Verderio, P....
Annals of Oncology. 27 (2016) 12 - p. 2283-2288 , 2016

Link: https://doi.org/10.1093/..

12

Sclerosing epithelioid fibrosarcoma of the thigh: report of..:

Righi, A. ; Gambarotti, M. ; Manfrini, M....
Virchows Archiv. 467 (2015) 3 - p. 339-344 , 2015

Link: https://doi.org/10.1007/..

13

Specialized teams or specialist networks for rare cancers?:

Sandrucci, S. ; Gatta, G. ; Trama, A...
European Journal of Surgical Oncology (EJSO). 41 (2015) 9 - p. 1115-1117 , 2015

Link: https://doi.org/10.1016/..

14

Rare Cancers Europe (RCE) methodological recommendations fo..:

Casali, P.G. ; Bruzzi, P. ; Bogaerts, J....
Annals of Oncology. 26 (2015) 2 - p. 300-306 , 2015

Link: https://doi.org/10.1093/..

15

Activity of sunitinib in extraskeletal myxoid chondrosarcom:

Stacchiotti, S. ; Pantaleo, M.A. ; Astolfi, A....
European Journal of Cancer. 50 (2014) 9 - p. 1657-1664 , 2014

Link: https://doi.org/10.1016/..